Breaking News

Tweet TWEET

Traders Look to New Levels Ahead - Research & Analysis on Amgen

Traders Look to New Levels Ahead - Research & Analysis on Amgen Inc.
and Glaxosmithkline Plc 
JAKARTA, INDONESIA -- (Marketwire) -- 10/23/12 --  Moments ago,
TradersInsight.net introduced new coverage of Amgen Inc. (NASDAQ:
AMGN) and Glaxosmithkline Plc (NYSE: GSK). Full outlook, analysis and
consensus opinion is available to readers via the links
below. 
www.TradersInsight.net/r/cnbc/b737_AMGN 
www.TradersInsight.net/r/cnbc/0771_GSK 
The consistent delivery of accurate analyses relies solely on two
factors, namely: market awareness and industry insight. Recent market
drivers include the spark of U.S. housing starts soaring past
expectations to a four-year high in September, industrial production
rising 0.4% in September 2012 beating expectations for a 0.2%
increase and the recent upward surprise in initial jobless claims
bouncing upward to 388,000 above expectations of 365,000 in the
latest week. When it comes to discovering the right edge at the right
time, all these factors play into effect. For a deeper understanding
of the mechanics behind these events and how it can affect your
portfolio, please refer to our email newsletter delivered to your
inbox. 
Traders Insight is releasing new coverage on Amgen Inc. for its
current position within the health care sector. Amgen Inc. (Amgen) is
a biotechnology medicines company. The Company discovers, develops,
manufactures and markets medicines for illnesses. It focuses solely
on human therapeutics and concentrates on medicines based on cellular
and molecular biology. A copy of this report featuring Amgen Inc.
(NASDAQ: AMGN) is available at:
www.TradersInsight.net/r/cnbc/b737_AMGN. 
Traders Insight has released research on Glaxosmithkline Plc for its
changing role within the consumer durables sector. GlaxoSmithKline
plc (GSK) is global healthcare group, which is engaged in the
creation and discovery, development, manufacture and marketing of
pharmaceutical products, including vaccines, over-the-counter (OTC)
medicines and health-related consumer products. To access the full
research report on Glaxosmithkline Plc (NYSE: GSK) we welcome
investors to visit: www.TradersInsight.net/r/cnbc/0771_GSK. 
About Traders Insight
 Find direction and insight with
TradersInsight.net. Our model of enabling open collaboration between
members is breaking new ground into the investment community. By
tapping into the resources of the community, we are crowd-sourcing
our reach. As a result -- we have been able to identify some of the
greatest moving companies on the market today. The evidence is in the
results, join today and experience what you've been missing. 
Contact: 
Cora S. Patton
press@TradersInsight.net
www.TradersInsight.net